Arcturus Therapeutics Holdings Inc. (ARCT) vs Canopy Growth Corporation (CGC)
A side-by-side comparison of Arcturus Therapeutics Holdings Inc. and Canopy Growth Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARCT
Arcturus Therapeutics Holdings Inc.
$14.02HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
CGC
Canopy Growth Corporation
$0.89HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
Total return — ARCT vs CGC
growth of $100 · dividends reinvested · last 10yARCT -19.5% (-2.1%/yr)CGC -97.6% (-31.2%/yr)ARCT compounded faster over this window
Log scale — wide-divergence pair
ARCT CGC
ARCT vs CGC: by the numbers
- •ARCT is the larger company ($398M vs $376M market cap).
- •Both run net losses; CGC's is the smaller (-81.04% vs -391.90% net margin).
- •ARCT grew revenue faster over the past five years (22.30% vs -12.47% CAGR).
Metrics side by side
Valuation
| Metric | ARCT | CGC |
|---|---|---|
| P/S ratio | 16.74 | 1.63 |
| P/B ratio | 2.32 | 0.78 |
Profitability
| Metric | ARCT | CGC |
|---|---|---|
| Gross margin | 95.50% | 25.47% |
| Operating margin | -111.51% | -31.98% |
| Net margin | -391.90% | -81.04% |
| ROE | -54.29% | -38.57% |
| ROIC | -54.07% | -10.85% |
Growth (annualized)
| Metric | ARCT | CGC |
|---|---|---|
| Revenue CAGR (5Y) | 22.30% | -12.47% |
| Total return CAGR (5Y) | -18.73% | -63.36% |
Frequently asked
- Which has grown faster, ARCT or CGC?
- Over the past five years, ARCT grew revenue faster — ARCT at a 22.30% CAGR versus CGC at -12.47%.
- How have ARCT and CGC total returns compared?
- Over the past 10 years, ARCT delivered -2.54% and CGC delivered -31.35% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Arcturus Therapeutics ROECanopy Growth ROEArcturus Therapeutics operating marginCanopy Growth operating marginArcturus Therapeutics revenue growthCanopy Growth revenue growthArcturus Therapeutics free cash flowCanopy Growth free cash flow
Arcturus Therapeutics & Canopy Growth appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.